If you can still read this message after the webpage has finished loading, then your browser may not be capable of using CSS to display this site correctly. Please view the website information page for further details.
More information will be available shortly. Thank you for your patience.
International Plenary Speakers
Photographs and biosketches will be added when available.
- Siobhan Brady, University of California, Davis, CA, USA
Siobhan Brady received her PhD at the University of Toronto in 2005, and was a Natural Sciences and Engineering Research Council of Canada Postdoctoral Fellow at Duke University from 2005 – 2008. In 2009 she began an Assistant Professor Position and became an Associate Professor in 2015 at the University of California, Davis in the Department of Plant Biology and in the Genome Center. In 2016 she was named as a Howard Hughes Medical Institute Faculty Research Scholar. Research in the Brady lab focuses on the global regulation of gene expression and its contribution to root morphology and development in Arabidopsis thaliana, Solanum species, Sorghum bicolor and maize.
- Jamie Cate, University of California, Berkeley, CA, USA
Dr. Cate has had a longstanding interest in understanding how the ribosome translates the genetic code into proteins. His lab studies human translation, focusing on the role of human translation initiation factor eIF3 and on ribosome stalling mechanisms. Using biochemical and structural biology, his lab has revealed fundamental mechanisms of human translation initiation, including the discovery of a 5’-m7G mRNA cap-binding activity in human eIF3 and eIF3-mediated regulation of specific mRNAs. His lab also revealed a new molecular mechanism of action for small molecules that can selectively stall protein synthesis on the human ribosome, in collaboration with Pfizer. Dr. Cate received his Ph.D. from the Department of Molecular Biophysics and Biochemistry at Yale University. After a Damon Runyon-Walter Winchell Cancer Research Fund Postdoctoral Fellowship at the University of California, Santa Cruz, he joined the faculty of MIT as an Associate Member of the Whitehead Institute for Biomedical Research. He is now Professor of Biochemistry, Biophysics and Structural Biology at the University of California, Berkeley. His research has been recognized with a Searle Scholar Award, AAAS Newcomb Cleveland Prize, and the Irving Sigal Young Investigator Award from The Protein Society. He is also a Member of the American Academy of Arts and Sciences.
- Jennifer Doudna, University of California, Berkeley, CA, USA
As an internationally renowned professor of Chemistry and Molecular and Cell Biology at U.C. Berkeley, Doudna and her colleagues rocked the research world in 2012 by describing a simple way of editing the DNA of any organism using an RNA-guided protein found in bacteria. This technology, called CRISPR-Cas9, has opened the floodgates of possibility for human and non-human applications of gene editing, including assisting researchers in the fight against HIV, sickle cell disease and muscular dystrophy. Doudna is an Investigator with the Howard Hughes Medical Instituteand a member of the National Academy of Sciences, the National Academy of Medicine, the National Academy of Inventors and the American Academy of Arts and Sciences. She is the co-author with Sam Sternberg of "A Crack in Creation", a personal account of her research and the societal and ethical implications of gene editing.
- Niko Geldner, Université de Lausanne, Lausanne, Switzerland
Niko Geldner studied biology at the Universities of Mainz, Bordeaux 2 and Tübingen. He did his PhD in the lab of Gerd Juergens, working Arabidopsis embryogenesis and auxin transport. He then went as an EMBO and HFSP fellow to Joanne Chory at the Salk Insitute in La Jolla, California, working on endosomal trafficking of the BRI1 recepter and developing the WAVE sub-cellular compartment markers. In 2007 he started as an Assistant Professor at the University of Lausanne and was promoted to Associate Professor in 2012 and Full Professor in 2018. He was awarded a starting and consolidator grant of the European Research Council (ERC) in 2007 and 2013. In 2011 he became an EMBO Young Investigator and was elected EMBO member in 2017.
- Cynthia Kenyon, Calico Life Sciences LLC, South San Francisco, CA, USA
Cynthia Kenyon is Vice President, Aging Research, at Calico and world expert on the genetics of aging. In 1993, Cynthia’s discovery that a single-gene mutation could double the lifespan of the roundworm C. elegans has led to a new understanding of the genetics of aging. She has received many honors and awards for her findings. Cynthia graduated valedictorian in chemistry and biochemistry from the University of Georgia in 1976. She received her PhD from MIT in 1981, and then did postdoctoral studies with Nobel laureate Sydney Brenner at the MRC Laboratory of Molecular Biology in Cambridge, UK. From 1986 she was at the University of California, San Francisco, where she was the Herbert Boyer Distinguished Professor and an American Cancer Society Professor. In 2014 she joined Calico. She is a member of the US National Academy of Sciences, the American Academy of Arts and Sciences, and the Institute of Medicine and she is a past president of the Genetics Society of America.
- Cristina Lo Celso, Imperial College London, London, UK
Dr Lo Celso graduated from Torino University in Italy. She obtained her PhD from UCL, working with Fiona Watt at the CRUK London Research Institute, where she studied epidermal stem cells. She started performing intravital microscopy of the haematopoietic stem cell (HSC) niche during her postdoctoral training at Harvard University with David Scadden. In 2009 she started her independent research group at Imperial College London, where she is now a reader in the department of Life Sciences, and network lead of the Imperial Stem Cell and Regenerative Medicine Network. Dr Lo Celso recently established a satellite laboratory at the Sir Francis Crick Institute. Her research aims to understand the mechanisms regulating HSC function during steady state and during stress, such as infections, leukaemia and transplantation. Her interdisciplinary approach combines mouse bone marrow intravital microscopy techniques, computational image analysis, molecular profiling and mathematical modelling of the HSC niche. Dr Lo Celso is the first woman to receive the Foulkes Medal award (2017). She received the ISEH New Investigator award in 2017, presented the DGZ Carl Zeiss Lecture 2018 and was awarded the Royal Microscopial Society Life Sciences medal 2019.
- Jodi Nunnari, University of California, Davis, USA
- Roy Parker, University of Colorado, Boulder, USA
Roy Parker is an Investigator with the Howard Hughes Medical Institute, Cech-Leinwand Endowed Chair of Biochemistry and Distinguished Professor at the University of Colorado Boulder. He received his Ph.D. from the University of California, San Francisco and completed his Postdoctoral work at the University of Massachusetts, Worcester. He has been on the editorial boards of MCB, Science, Cell, RNA, and Nucleic Acids Research. He was the President of the RNA Society (2010), and has been elected to the American Academy of Arts & Sciences (2010) and the National Academy of Sciences (2012).
- Daniel St Johnston, Gurdon Institute, Cambridge, UK
- Emma Teeling, University College, Dublin, UK